miscsubjectsAI governance
Evidence review

SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-nsaids`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-nsaids

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-nsaids/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-nsaids/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-nsaids/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-nsaids/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have NSAIDs

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why SS-31 (Elamipretide) might help you

  1. You are reading about NSAIDs — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

Why NSAIDs matters for you

  1. Drug: NSAIDs
  2. What it does: Suppress inflammation signal; may slow structural repair cascade.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • SS-31 (Elamipretide) → mitochondrial

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 2
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.39 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice (source s0)

Rodent study showing SS-31 protection in LPS inflammation model.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Elamipretide: A Review of Its Structure, Mechanism of Action... (source s11)

Detailed mechanism review.

Evidence type: Published research.

Safety and limits

  1. Provider materials note caution combining SS-31 with chronic NSAIDs due to renal clearance.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

NSAIDs · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 5 sources · swipe →chain a34528933728 · verify chain · provenance
Evidence ledger 7 · tier-ranked · API
anecdotal
Provider materials note caution combining SS-31 with chronic NSAIDs due to renal clearance.
sources: s10
human
No published human trials on SS-31 and NSAID cross.
preclinical
Chronic NSAID use linked to mitochondrial stress in kidney/gut cells in preclinical models.
preclinical
Rodent LPS inflammation model showed SS-31 improved mitochondrial function and ATP (preclinical).
sources: s0
mechanistic
NSAIDs suppress inflammation via COX inhibition but may slow structural repair.
2 more ranked claims
human0.22low confidence
FDA approval of elamipretide for Barth syndrome in 2025 based on TAZPOWER trial muscle strength data (human).
grok/grok-4.3
Highest-tier human evidence for the compound.
sources: s2
mechanistic0.22low confidence
SS-31 binds cardiolipin, stabilizes mitochondrial cristae, and supports ETC efficiency (mechanistic).
grok/grok-4.3
Core mechanism explaining potential relevance to any mitochondrial stress.
sources: s5, s11
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:51
SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression · 7 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Nsaids
Slug: ss-31-nsaids
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"NSAIDs","condition_key":"nsaids","primary_peptide":"ss-31","peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":["nsaids"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down if you have NS
it output
{
  "slug": "ss-31-nsaids",
  "title": "SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression",
  "body": "## What's breaking down if you have NSAIDs\n\nNSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. This suppresses the inflammatory response but can slow the natural repair processes that follow tissue stress. Chronic use has been linked in preclinical work to mitochondrial stress in kidney and gut cells through oxidative load and altered energy handling. If your NSAID use contributes to ongoing cellular fatigue or slower recovery in those tissues, the core issue sits at the mitochondrial level where energy production and ROS management decline faster than repair mechanisms restore them.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 binds cardiolipin in the inner mitochondrial membrane. This stabilizes cristae structure and supports electron transport chain efficiency. If NSAID-related oxidative stress has impaired mitochondrial ATP output in your cells, SS-31 is studied for restoring membrane potential and reducing electron leak. Preclinical rodent models of LPS-ind
c0013aa955730958
Machine verification: /api/articles/ss-31-nsaids/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (anecdotal tier): "Provider materials note caution combining SS-31 with chronic NSAIDs due to renal clearance."?
ask ss-31-nsaids claim c7 · paste includes §SELF
What does the ledger say about this (human tier): "No published human trials on SS-31 and NSAID cross."?
ask ss-31-nsaids claim c6 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Chronic NSAID use linked to mitochondrial stress in kidney/gut cells in preclinical models."?
ask ss-31-nsaids claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Rodent LPS inflammation model showed SS-31 improved mitochondrial function and ATP (preclinical)."?
ask ss-31-nsaids claim c4 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "NSAIDs suppress inflammation via COX inhibition but may slow structural repair."?
ask ss-31-nsaids claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "FDA approval of elamipretide for Barth syndrome in 2025 based on TAZPOWER trial muscle strength data (human)."?
ask ss-31-nsaids claim c5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression — and what would you need me to tell you first?
ask ss-31-nsaids condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression (studies vs anecdotes)?
ask ss-31-nsaids good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…